|
"yu ming lung"的相關文件
顯示項目 36-60 / 92 (共4頁)
<< < 1 2 3 4 > >>
每頁顯示[10|25|50]項目
| 國立交通大學 |
2019-04-02T05:59:55Z |
Association of hyperuricemia with disease severity in chronic hepatitis C patients
|
Jang, Tyng-Yuan; Yeh, Ming-Lun; Huang, Ching-, I; Lin, Zu-Yau; Chen, Shinn-Cherng; Hsieh, Meng-Hsuan; Dai, Chia-Yen; Huang, Jee-Fu; Huang, Chung-Feng; Chuang, Wan-Long; Yu, Ming-Lung |
| 國立交通大學 |
2019-04-02T05:59:50Z |
Reply to "The choice of antiviral therapy for hepatitis C recurrence after liver transplantation in the real world"
|
Yu, Ming-Lung |
| 國立交通大學 |
2019-04-02T05:59:49Z |
Lower protein expression levels of MHC class I chain-related gene A in hepatocellular carcinoma are at high risk of recurrence after surgical resection
|
Huang, Chung-Feng; Wang, Shu-Chi; Chang, Wen-Tsan; Yeh, Ming-Lun; Huang, Ching-I; Lin, Zu-Yau; Chen, Shinn-Cherng; Chuang, Wan-Long; Huang, Jee-Fu; Dai, Chia-Yen; Chen, Yao-Li; Yu, Ming-Lung |
| 國立交通大學 |
2019-04-02T05:59:44Z |
Autophagy-related gene LC3 expression in tumor and liver microenvironments significantly predicts recurrence of hepatocellular carcinoma after surgical resection
|
Lin, Chih-Wen; Chen, Yaw-Sen; Lin, Chih-Che; Lee, Po-Huang; Lo, Gin-Ho; Hsu, Chia-Chang; Hsieh, Pei-Min; Koh, Kah Wee; Chou, Tsung-Ching; Dai, Chia-Yen; Huang, Jee-Fu; Chuang, Wan-Long; Chen, Yao-Li; Yu, Ming-Lung |
| 國立交通大學 |
2019-04-02T05:59:37Z |
A real world cost effectiveness analysis of interferon-based therapy for HCV naive super-responders
|
Tsai, Pei-Chien; Liu, Ta-Wei; Huang, Chung-Feng; Yeh, Ming-Lun; Dai, Chia-Yen; Chuang, Wan-Long; Huang, Jee-Fu; Yu, Ming-Lung |
| 國立交通大學 |
2019-04-02T05:59:10Z |
Post-treatment fibrotic modifications overwhelm pretreatment liver fibrosis in predicting HCC in CHC patients with curative antivirals
|
Huang, Chung-Feng; Yeh, Ming-Lun; Huang, Ching-I; Liang, Po-Cheng; Lin, Yi-Hung; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu; Dai, Chia-Yen; Chuang, Wan-Long; Yu, Ming-Lung |
| 國立交通大學 |
2019-04-02T05:57:55Z |
Significant predictors of overall survival in patients with hepatocellular carcinoma after surgical resection
|
Lin, Chih-Wen; Chen, Yaw-Sen; Lin, Chih-Che; Lee, Po-Huang; Lo, Gin-Ho; Hsu, Chia-Chang; Hsieh, Pei-Min; Koh, Kah Wee; Bair, Ming-Jong; Dai, Chia-Yen; Huang, Jee-Fu; Chuang, Wan-Long; Chen, Yao-Li; Yu, Ming-Lung |
| 臺大學術典藏 |
2019-03-15T07:44:51Z |
Association between urinary thiodiglycolic acid level and hepatic function or fibrosis index in school-aged children living near a petrochemical complex
|
Huang, Po-Chin;Chiang, Hung-Che;Chuang, Hung-Yi;Yu, Ming-Lung;Liao, Kai-Wei;Wang, Chih-Wen;Chang-Chuan Chan; Wang, Chih-Wen; Liao, Kai-Wei; CHANG-CHUAN CHAN; Yu, Ming-Lung; Chuang, Hung-Yi; Chiang, Hung-Che; Huang, Po-Chin |
| 臺大學術典藏 |
2019 |
Genome-wide DNA hypermethylation and homocysteine increase a risk for myopia
|
YUNG-SONG WANG; Liang, Chung-Ling; Huang, Chia-Wei; Yu, Ming-Lung; Juo, Suh-Hang Hank; Wang, Yung-Song; Hsi, Edward; Hsi, Edward;Wang, Yung-Song;Huang, Chia-Wei;Yu, Ming-Lung;Juo, Suh-Hang Hank;Liang, Chung-Ling |
| 臺大學術典藏 |
2018-09-10T15:22:34Z |
Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial
|
Liu, Chen-Hua;Huang, Chung-Feng;Liu, Chun-Jen;Dai, Chia-Yen;Huang, Jee-Fu;Lin, Jou-Wei;Liang, Cheng-Chao;Yang, Sheng-Shun;Lin, Chih-Lin;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Kao, Jia-Horng;Yu, Ming-Lung; Liu, Chen-Hua;Huang, Chung-Feng;Liu, Chun-Jen;Dai, Chia-Yen;Huang, Jee-Fu;Lin, Jou-Wei;Liang, Cheng-Chao;Yang, Sheng-Shun;Lin, Chih-Lin;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Kao, Jia-Horng;Yu, Ming-Lung; Liu, C.-H. and Huang, C.-F. and Liu, C.-J. and Dai, C.-Y. and Huang, J.-F. and Lin, J.-W. and Liang, C.-C. and Yang, S.-S. and Lin, C.-L. and Su, T.-H. and Yang, H.-C. and Chen, P.-J. and Chen, D.-S. and Chuang, W.-L. and Kao, J.-H. and Yu, M.-L.; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲;林昭維; Liu, Chen-Hua; HUNG-CHIH YANG; CHUN-JEN LIU; Huang, Chung-Feng; PEI-JER CHEN; Liu, Chun-Jen; Dai, Chia-Yen; CHEN-HUA LIU; DING-SHINN CHEN; Huang, Jee-Fu; Lin, Jou-Wei; TUNG-HUNG SU; JIA-HORNG KAO; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung |
| 臺大學術典藏 |
2018-09-10T15:18:57Z |
Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trial
|
Liu, Chen-Hua;Huang, Chung-Feng;Liu, Chun-Jen;Dai, Chia-Yen;Huang, Jee-Fu;Lin, Jou-Wei;Liang, Cheng-Chao;Yang, Sheng-Shun;Lin, Chih-Lin;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Kao, Jia-Horng;Yu, Ming-Lung; Liu, Chen-Hua;Huang, Chung-Feng;Liu, Chun-Jen;Dai, Chia-Yen;Huang, Jee-Fu;Lin, Jou-Wei;Liang, Cheng-Chao;Yang, Sheng-Shun;Lin, Chih-Lin;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Kao, Jia-Horng;Yu, Ming-Lung; Liu, C.-H. and Huang, C.-F. and Liu, C.-J. and Dai, C.-Y. and Huang, J.-F. and Lin, J.-W. and Liang, C.-C. and Yang, S.-S. and Lin, C.-L. and Su, T.-H. and Yang, H.-C. and Chen, P.-J. and Chen, D.-S. and Chuang, W.-L. and Kao, J.-H. and Yu, M.-L.; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲;林昭維; Wu, Cho-Kai; Liu, Chen-Hua; HUNG-CHIH YANG; CHUN-JEN LIU; Su, Mao-Yuan; Huang, Chung-Feng; PEI-JER CHEN; Lee, Jen-Kuang; Liu, Chun-Jen; Dai, Chia-Yen; Chiang, Fu-Tien; CHEN-HUA LIU; Hwang, Juey-Jen; Huang, Jee-Fu; DING-SHINN CHEN; Lin, Jiunn-Lee; TUNG-HUNG SU; Lin, Jou-Wei; JIA-HORNG KAO; Chen, Jin-Jer; Liang, Cheng-Chao; Yang, Sheng-Shun; Liu, Fu-Tong; Lin, Chih-Lin; Tsai, Chia-Ti; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung; ??????; ?L?T??; ?????; ??Z??; ?d????; ???礯; ?????? |
| 臺大學術典藏 |
2018-09-10T15:18:57Z |
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial
|
DING-SHINN CHEN; Hung, Peir-Haur; Tsai, Hung-Bin; JIA-HORNG KAO; Lee, Chih-Yuan; Chen, Shih-I; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng; TUNG-HUNG SU; Liu, Chen-Hua;Liu, Chun-Jen;Huang, Chung-Feng;Lin, Jou-Wei;Dai, Chia-Yen;Liang, Cheng-Chao;Huang, Jee-Fu;Hung, Peir-Haur;Tsai, Hung-Bin;Tsai, Meng-Kun;Lee, Chih-Yuan;Chen, Shih-I;Yang, Sheng-Shun;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Yu, Ming-Lung;Kao, Jia-Horng; Liu, C.-H. and Liu, C.-J. and Huang, C.-F. and Lin, J.-W. and Dai, C.-Y. and Liang, C.-C. and Huang, J.-F. and Hung, P.-H. and Tsai, H.-B. and Tsai, M.-K. and Lee, C.-Y. and Chen, S.-I. and Yang, S.-S. and Su, T.-H. and Yang, H.-C. and Chen, P.-J. and Chen, D.-S. and Chuang, W.-L. and Yu, M.-L. and Kao, J.-H.; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;李志元;劉俊人;陳世宜;陳培哲;蔡孟昆;林昭維;蔡宏斌; HUNG-CHIH YANG; Liu, Chen-Hua; Liu, Chun-Jen; MENG-KUN TSAI; Huang, Chung-Feng; CHUN-JEN LIU; PEI-JER CHEN; Lin, Jou-Wei; HUNG-BIN TSAI; Dai, Chia-Yen; Liang, Cheng-Chao; CHEN-HUA LIU; Huang, Jee-Fu |
| 臺大學術典藏 |
2018-09-10T15:18:40Z |
Circulating mRNA Profiling in Esophageal Squamous Cell Carcinoma Identifies FAM84B As A Biomarker in Predicting Pathological Response to Neoadjuvant Chemoradiation
|
陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 林昭維; Hsu, Feng-Ming; Liu, Chen-Hua; YIH-LEONG CHANG; Cheng, Jason Chia-Hsien; Huang, Chung-Feng; ERIC YAO-YU CHUANG; Chang, Yih-Leong; JANG-MING LEE; Liu, Chun-Jen; Dai, Chia-Yen; Lee, Jang-Ming; Huang, Jee-Fu; Koong, Albert C.; Lin, Jou-Wei; Chuang, Eric Y.; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung; Hsu, Feng-Ming;Cheng, Jason Chia-Hsien;Chang, Yih-Leong;Lee, Jang-Ming;Koong, Albert C.;Chuang, Eric Y.; Hsu, F.-M. and Cheng, J.C.-H. and Chang, Y.-L. and Lee, J.-M. and Koong, A.C. and Chuang, E.Y.; 張逸良;成佳憲;李章銘;許峰銘; 成佳憲 |
| 臺大學術典藏 |
2018-09-10T09:49:32Z |
Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotype
|
Huang, Chung-Feng;Yu, Ming-Lung;Kao, Jia-Horng;Tseng, Tai-Chung;Yeh, Ming-Lun;Huang, Jee-Fu;Dai, Chia-Yen;Lin, Zu-Yau;Chen, Shinn-Cherng;Wang, Liang-Yen;Juo, Suh-Hang Hank;Chuang, Wan-Long;Liu, Chen-Hua; CHEN-HUA LIU; Huang, Chung-Feng; Yu, Ming-Lung; JIA-HORNG KAO; Kao, Jia-Horng; Kao, Jia-Horng; Tseng, Tai-Chung; Tseng, Tai-Chung; Yeh, Ming-Lun; Yeh, Ming-Lun; Huang, Jee-Fu; Dai, Chia-Yen; Lin, Zu-Yau; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chuang, Wan-Long; Chuang, Wan-Long; Liu, Chen-Hua; Liu, Chen-Hua |
| 臺大學術典藏 |
2018-09-10T09:49:30Z |
Consolidation therapy for HBeAg-positive Asian chronic hepatitis B patients receiving lamivudine treatment: A multicentre study
|
Wong, Grace Lai Hung; JIA-HORNG KAO; Huang, Jee-Fu; Wong, Vincent Wai Sun; Wong, Vincent Wai Sun; Liu, Chun-Jen; Liu, Chun-Jen; Yu, Ming-Lung; Chuang, Wan-Long; Chuang, Wan-Long; Kao, Jia-Horng; Kao, Jia-Horng; Chan, Henry Lik Yuen; Chen, Ding-Shinn; Chen, Ding-Shinn; Tseng, Tai-Chung; Wong, Grace Lai Hung; DING-SHINN CHEN; Dai, Chia-Yen; CHUN-JEN LIU; Dai, Chia-Yen;Tseng, Tai-Chung;Wong, Grace Lai Hung;Huang, Jee-Fu;Wong, Vincent Wai Sun;Liu, Chun-Jen;Yu, Ming-Lung;Chuang, Wan-Long;Kao, Jia-Horng;Chan, Henry Lik Yuen;Chen, Ding-Shinn |
| 臺大學術典藏 |
2018-09-10T09:47:26Z |
Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion
|
Yang, Hung-Chih;Chen, Chi-Ling;Shen, Yueh-Chi;Peng, Cheng-Yuan;Liu, Chun-Jen;Tseng, Tai-Chung;Su, Tung-Hung;Chuang, Wan-Long;Yu, Ming-Lung;Dai, Chia-Yen;Liu, Chen-Hua;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Yang, Hung-Chih;Chen, Chi-Ling;Shen, Yueh-Chi;Peng, Cheng-Yuan;Liu, Chun-Jen;Tseng, Tai-Chung;Su, Tung-Hung;Chuang, Wan-Long;Yu, Ming-Lung;Dai, Chia-Yen;Liu, Chen-Hua;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Yang, H.-C. and Chen, C.-L. and Shen, Y.-C. and Peng, C.-Y. and Liu, C.-J. and Tseng, T.-C. and Su, T.-H. and Chuang, W.-L. and Yu, M.-L. and Dai, C.-Y. and Liu, C.-H. and Chen, P.-J. and Chen, D.-S. and Kao, J.-H.; 陳定信 ;劉振驊 ;高嘉宏 ;楊宏志 ;蘇東弘 ;劉俊人 ;陳培哲 ;陳祈玲; Yang, Hung-Chih; HUNG-CHIH YANG; CHUN-JEN LIU; Chen, Chi-Ling; Shen, Yueh-Chi; PEI-JER CHEN; Peng, Cheng-Yuan; CHEN-HUA LIU; TUNG-HUNG SU; Liu, Chun-Jen; Liu, Chun-Jen; Tseng, Tai-Chung; DING-SHINN CHEN; Tseng, Tai-Chung; Su, Tung-Hung; Su, Tung-Hung; JIA-HORNG KAO; Chuang, Wan-Long; Yu, Ming-Lung; Dai, Chia-Yen; Liu, Chen-Hua; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Chen, Ding-Shinn; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T09:39:55Z |
Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up.
|
Yu, Ming-Lung; HUNG-CHIH YANG; CHUN-JEN LIU; Lee, Chuan-Mo; Lee, Chuan-Mo; PEI-JER CHEN; Chen, Chi-Ling; Chen, Chi-Ling; CHEN-HUA LIU; Chuang, Wan-Long; Lu, Sheng-Nan; Lu, Sheng-Nan; DING-SHINN CHEN; Liu, Chen-Hua; JIA-HORNG KAO; Liu, Chen-Hua; Wu, Shun-Sheng; Wu, Shun-Sheng; Liao, Li-Ying; Kuo, Hsing-Tao; Kuo, Hsing-Tao; Chao, You-Chen; Tung, Shui-Yi; Tung, Shui-Yi; Yang, Sien-Sing; Kao, Jia-Horng; Kao, Jia-Horng; Su, Wei-Wen; Su, Wei-Wen; Lin, Chih-Lin; Lin, Chih-Lin; Yang, Hung-Chih; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Chen, Ding-Shinn; Liu, Chun-Jen; Liu, Chun-Jen; Yu, Ming-Lung;Lee, Chuan-Mo;Chen, Chi-Ling;Chuang, Wan-Long;Lu, Sheng-Nan;Liu, Chen-Hua;Wu, Shun-Sheng;Liao, Li-Ying;Kuo, Hsing-Tao;Chao, You-Chen;Tung, Shui-Yi;Yang, Sien-Sing;Kao, Jia-Horng;Su, Wei-Wen;Lin, Chih-Lin;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Liu, Chun-Jen |
| 臺大學術典藏 |
2018-09-10T09:39:54Z |
Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial.
|
Dai, Chia-Yen; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; Hung, Peir-Haur; Tsai, Hung-Bin; Tsai, Hung-Bin; Tsai, Meng-Kun; Chen, Shih-I; Lin, Jou-Wei; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng; 陳定信; Liu, Chen-Hua;Huang, Chung-Feng;Liu, Chun-Jen;Dai, Chia-Yen;Liang, Cheng-Chao;Huang, Jee-Fu;Hung, Peir-Haur;Tsai, Hung-Bin;Tsai, Meng-Kun;Chen, Shih-I;Lin, Jou-Wei;Yang, Sheng-Shun;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Yu, Ming-Lung;Kao, Jia-Horng; Liu, Chun-Jen; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳世宜;陳培哲;蔡孟昆;林昭維;蔡宏斌; Liu, Chen-Hua; Liu, Chen-Hua; CHEN-HUA LIU; Huang, Chung-Feng; Huang, Chung-Feng; Liu, Chun-Jen |
| 臺大學術典藏 |
2018-09-10T09:23:49Z |
APASL consensus statements and management algorithms for hepatitis C virus infection
|
Omata, Masao;Kanda, Tatsuo;Yu, Ming-Lung;Yokosuka, Osamu;Lim, Seng-Gee;Jafri, Wasim;Tateishi, Ryosuke;Hamid, Saeed S.;Chuang, Wan-Long;Chutaputti, Anuchit;Wei, Lai;Sollano, Jose;Sarin, Shiv Kumar;Kao, Jia-Horng;Mccaughan, Geoffrey W.; Omata, Masao; Omata, Masao; JIA-HORNG KAO; Kanda, Tatsuo; Yu, Ming-Lung; Yu, Ming-Lung; Yokosuka, Osamu; Yokosuka, Osamu; Lim, Seng-Gee; Lim, Seng-Gee; Jafri, Wasim; Jafri, Wasim; Tateishi, Ryosuke; Tateishi, Ryosuke; Hamid, Saeed S.; Hamid, Saeed S.; Chuang, Wan-Long; Chutaputti, Anuchit; Chutaputti, Anuchit; Wei, Lai; Wei, Lai; Sollano, Jose; Sollano, Jose; Sarin, Shiv Kumar; Kao, Jia-Horng; Kao, Jia-Horng; McCaughan, Geoffrey W.; McCaughan, Geoffrey W. |
| 臺大學術典藏 |
2018-09-10T09:14:10Z |
Revisiting the stopping rule for hepatitis C genotype 1 patients treated with peginterferon plus ribavirin.
|
Yu, Ming-Lung; Liu, Chen-Hua; Huang, Chung-Feng; Tseng, Tai-Chung; Huang, Jee-Fu; Dai, Chia-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chuang, Wan-Long; Kao, Jia-Horng; Re, Valli De; CHEN-HUA LIU; Yu, Ming-Lung; Liu, Chen-Hua; JIA-HORNG KAO; Liu, Chen-Hua; Huang, Chung-Feng; Tseng, Tai-Chung; Huang, Jee-Fu; Dai, Chia-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chuang, Wan-Long; Kao, Jia-Horng; Kao, Jia-Horng; RE, Valli DE |
| 臺大學術典藏 |
2018-09-10T07:37:25Z |
Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
|
Liu, Chun-Jen;Chuang, Wan-Long;Lee, Chuan-Mo;Yu, Ming-Lung;Lu, Sheng-Nan;Wu, Shun-Sheng;Chen, Chi-Ling;Yang, Sien-Sing;Kao, Jia-Horng;Liu, Chen-Hua;Su, Wei-Wen;Jeng, Yung-Ming;Chen, Pei-Jer;Chen, Ding-Shinn; CHUN-JEN LIU; YUNG-MING JENG; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO; LIU, CHUN-JEN; CHUANG, WAN-LONG; LEE, CHUAN-MO; YU, MING-LUNG; LU, SHENG-NAN; WU, SHUN-SHENG; CHEN, CHI-LING; YANG, SIEN-SING; KAO, JIA-HORNG; LIU, CHEN-HUA; SU, WEI-WEN; JENG, YUNG-MING; CHEN, PEI-JER; CHEN, DING-SHINN |
| 臺大學術典藏 |
2018-09-10T05:02:40Z |
RBMY, a male germ cell-specific RNA-binding protein, activated in human liver cancers and transforms rodent fibroblasts
|
Tsuei, DJ;Hsu, HC;Lee, PH;Jeng, YM;Pu, YS;Chen, CN;Lee, YC;Chou, WC;Chang, CJ;Ni, YH;Chang, MH.; Tsuei, D.-J. and Hsu, H.-C. and Lee, P.-H. and Jeng, Y.-M. and Pu, Y.-S. and Chen, C.-N. and Lee, Y.-C. and Chou, W.-C. and Chang, C.-J. and Ni, Y.-H. and Chang, M.-H.; Liu, Chen-Hua; Tsuei, DJ; PO-HUANG LEE; Hsu, HC; Huang, Chung-Feng; MEI-HWEI CHANG; Lee, PH; Liu, Chun-Jen; CHIUNG-NIEN CHEN; YUNG-MING JENG; Dai, Chia-Yen; Jeng, YM; Yen-Hsuan Ni; Huang, Jee-Fu; Pu, YS; Chen, CN; Lin, Jou-Wei; YEONG-SHIAU PU; Lee, YC; Liang, Cheng-Chao; Chou, WC; Yang, Sheng-Shun; Lin, Chih-Lin; Chang, CJ; Su, Tung-Hung; Ni, YH; Yang, Hung-Chih; Chang, MH.; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 林昭維 |
| 國立交通大學 |
2018-08-21T05:53:33Z |
Interference of hepatitis B virus dual infection in platelet count recovery in chronic hepatitis C patients with curative antiviral therapy
|
Huang, Chung-Feng; Yeh, Ming-Lun; Huang, Ching-I; Lin, Zu-Yau; Chen, Shinn-Cherng; Dai, Chia-Yen; Huang, Jee-Fu; Chuang, Wan-Long; Yu, Ming-Lung |
| 國立交通大學 |
2018-08-21T05:53:04Z |
Treating hepatitis C in the elderly: pharmacotherapeutic considerations and developments
|
Huang, Chung-Feng; Yu, Ming-Lung |
| 嘉南藥理大學 |
2016-04 |
Nonalcoholic fatty liver disease severity is associated with the ratios of total cholesterol and triglycerides to high-density lipoprotein cholesterol
|
Wu, Kuan-Ta; Kuo, Po-Lin; Su, Shih-Bin; Chen, Yi-Yu; Yeh, Ming-Lum; Huang, Ching-I; Yang, Jeng-Fu; Lin, Chia-I; Hsieh, Meng-Hsuan; Hsieh, Ming-Yen; Huang, Chung-Feng; Lin, Wen-Yi; Yu, Ming-Lung; Dai, Chia-Yen; Wang, Hsien-Yi |
顯示項目 36-60 / 92 (共4頁)
<< < 1 2 3 4 > >>
每頁顯示[10|25|50]項目
|
